What type of antihypertensive drug is bosutinib?

Bosutinib (Bosutinib) is not a blood pressure drug, but a drug that treats chronic myeloid leukemia (CML). It belongs to a class of drugs called tyrosine kinase inhibitors, which are primarily used to inhibit the growth and replication of abnormally proliferating leukemia cells. This medicine is only available with a doctor's prescription. Bosutinib may have negative effects on heart function, including cardiac arrhythmias and heart failure.

Bosutinib is used to treat chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) that is newly diagnosed or has failed to respond to other drugs. This drug is also used to treat patients with accelerated phase (AP) or blast phase (BP) Ph+ CML who are taking other drugs but have failed to respond. Leukemia is a cancer in which the body produces abnormal white blood cells. Bosutinib is an anti-tumor drug. It interferes with the growth of cancer cells, which are eventually eliminated by the body. Because the growth of normal cells may also be affected by bosutinib, other side effects may occur.

The originator drug of bosutinib is not marketed in the country, so it cannot be included in medical insurance. Currently, the original drugs sold overseas include Turkish version and European version. The price of the Turkish version may be more than RMB 2,000 per box of 500mg*28, and the price of the European version may be more than RMB 30,000 (the price may fluctuate due to the exchange rate). There are also bosutinib generic drugs produced overseas in other countries. Their pharmaceutical ingredients are basically the same as those of the original drug. The price of 500mg*30 per box may be more than 2,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.